Sign Out
Posology: The recommended dose of ANASTROZOLE 1 EURODRUG for adults including the elderly in one 1 mg tablet once a day.
For postmenopausal women with hormone receptor-positive early invasive breast cancer, the recommended duration of adjuvant endocrine treatment is 5 years.
Special populations: Paediatric population: ANASTROZOLE 1 EURODRUG is not recommended for use in children and adolescents due to insufficient data on safety and efficacy (see Precautions and PHARMACOLOGY: Pharmacodynamics under Actions).
Renal impairment: No dose change is recommended in patients with mild or moderate renal impairment. In patients with severe renal impairment, administration of ANASTROZOLE 1 EURODRUG should be performed with caution (see Precautions and PHARMACOLOGY: Pharmacokinetics under Actions).
Hepatic impairment: No dose change is recommended in patients with mild hepatic disease. Caution is advised in patients with moderate to severe hepatic impairment (see Precautions).
Method of administration: Oral administration.
